SBI Healthcare Opportunities Fund-growth
Latest AUM
₹ 4,063.6 Cr.
NAV as on 01 jun, 2026
₹ 456.43
Fund Details
Portfolio Composition Analysis
Sector Allocations
Portfolio Updated on: 01 jun, 2026
Top 10 Holdings
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 1.00% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.97% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 12.11% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.64% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.18% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 11.18% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.65% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.86% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.94% |
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.02% |
Debt & Credit Risk Analysis
| Alpha | 1.78% |
| Beta | 0.85% |
| Sharpe Ratio | 1.15% |
| Standard Deviation | 14.71% |
Returns Analysis
| Tenure | Absolute | Annualised | Category Average |
|---|---|---|---|
| 3 Months | 5.80% | NA | 6.12% |
| 6 Months | 5.16% | NA | 12.92% |
| 9 Months | 6.45% | NA | 4.47% |
| 1 Year | 9.18% | 9.18% | 6.04% |
| 2 Years | 34.56% | 16.00% | 24.93% |
| 3 Years | 92.28% | 24.35% | 25.71% |
| 5 Years | 103.33% | 15.25% | 19.91% |
| 7 Years | 305.28% | 22.13% | NA |
| 10 Years | 236.17% | 12.89% | 12.78% |
SBI Healthcare Opportunities Fund-growth is one Equity mutual fund offered by SBI Mutual Fund. Launched on 05 Jul 1999, the fund aims Long term capital appreciation. Equity investments in stocks of companies in the healthcare sector. It manages assets worth ₹4,063.6 crore as on Tue Mar 31, 2026. The expense ratio stands at 1.93%.
Pradeep Kesavan has experience Prior to joining SBI MF, he has worked with Elara Capital, Accenture Strategy, Morgan Stanley and 3i Infotech
Tanmaya Desai has experience Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
Top Performing Mutual Funds
growth is based on 1-month returns of the funds & Top fund are based on 3Y Returns
More Funds from SBI Mutual Fund
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +4.00% | +6.07% | +5.69% | +10.29% | +25.66% | +16.47% |
| SBI Healthcare Opportunities Fund-idcw | 4,063.6 | +3.91% | +5.80% | +5.16% | +9.18% | +24.35% | +15.25% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw | 4,063.6 | +4.00% | +6.07% | +5.69% | +10.29% | +25.66% | +16.47% |
growth is based on 1-month returns of the funds
Top Mutual Funds
| Fund name | |||||||
|---|---|---|---|---|---|---|---|
| Nippon India Pharma Fund Direct-growth | 7,898.2 | +2.37% | +2.91% | +2.90% | +5.82% | +22.93% | +13.62% |
| Nippon India Pharma Fund-growth | 7,898.2 | +2.29% | +2.68% | +2.45% | +4.88% | +21.84% | +12.60% |
| Nippon India Pharma Fund-idcw | 7,898.2 | +2.29% | +2.68% | +2.45% | +4.88% | +21.84% | +12.60% |
| Nippon India Pharma Fund Direct-idcw | 7,898.2 | +2.37% | +2.91% | +2.90% | +5.82% | +22.93% | +13.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | 6,293.1 | +2.58% | +6.59% | +2.18% | +7.19% | +27.68% | +16.50% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | 6,293.1 | +2.53% | +6.38% | +1.79% | +6.32% | +26.62% | +15.49% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | 6,293.1 | +2.58% | +6.59% | +2.18% | +7.19% | +27.68% | +16.50% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | 6,293.1 | +2.53% | +6.38% | +1.79% | +6.32% | +26.62% | +15.49% |
| SBI Healthcare Opportunities Fund Direct Plan-growth | 4,063.6 | +4.00% | +6.07% | +5.69% | +10.29% | +25.66% | +16.47% |
Top funds are based on Fund AUM
Top Equity Funds
| Fund name | ||||
|---|---|---|---|---|
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth | ₹44.47 | +27.68% | +16.50% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw | ₹26.86 | +27.68% | +16.50% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-growth | ₹527.29 | +25.66% | +16.47% | — |
| Sbi Healthcare Opportunities Fund Direct Plan-idcw | ₹366.35 | +25.66% | +16.47% | — |
| Mirae Asset Healthcare Fund Direct-growth | ₹46.76 | +26.14% | +15.83% | — |
| Mirae Asset Healthcare Fund Direct-idcw | ₹28.17 | +26.14% | +15.83% | — |
| Dsp Healthcare Fund Direct-growth | ₹45.22 | +23.33% | +15.52% | — |
| Dsp Healthcare Fund Direct-idcw | ₹26.15 | +23.33% | +15.52% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth | ₹40.99 | +26.62% | +15.49% | — |
| Icici Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw | ₹23.91 | +26.62% | +15.49% | — |
growth is based on 5Y returns of the funds
Historical NAV
| Date | NAV |
|---|---|
| 01 Jun 2026 | ₹456.43 |
| 31 May 2026 | ₹459.29 |
| 29 May 2026 | ₹459.33 |
| 27 May 2026 | ₹463.12 |
| 26 May 2026 | ₹465.33 |
| 25 May 2026 | ₹465.81 |
| 22 May 2026 | ₹466.26 |
| 21 May 2026 | ₹470.64 |
| 20 May 2026 | ₹467.30 |
| 19 May 2026 | ₹466.76 |
| 18 May 2026 | ₹464.01 |
| 15 May 2026 | ₹461.27 |
| 14 May 2026 | ₹462.52 |
| 13 May 2026 | ₹457.20 |
| 12 May 2026 | ₹455.53 |
| 11 May 2026 | ₹461.80 |
| 08 May 2026 | ₹457.42 |
| 07 May 2026 | ₹455.80 |
| 06 May 2026 | ₹454.48 |
| 05 May 2026 | ₹447.27 |
| 04 May 2026 | ₹446.92 |
| 30 Apr 2026 | ₹439.26 |
| 29 Apr 2026 | ₹438.27 |
| 28 Apr 2026 | ₹436.91 |
| 27 Apr 2026 | ₹438.10 |
| 24 Apr 2026 | ₹426.36 |
| 23 Apr 2026 | ₹432.92 |
| 22 Apr 2026 | ₹431.78 |
| 21 Apr 2026 | ₹430.43 |
| 20 Apr 2026 | ₹430.15 |
Portfolio Updated on: 02 Jun, 2026
Fund Growth & Size Analysis
Compare Mutual funds
SBI Healthcare Opportunities Fund-growth Returns Comparison
Compare SBI Healthcare Opportunities Fund-growth with any MF,
EYF, stock or index
No funds found for your search.
SBI Healthcare Opportunities Fund-growth FAQ'S
- Sharpe Ratio: 1.15%
- Standard Deviation: 14.71%
- Beta: 0.85%
- Alpha: 1.78%
Additional important ratios:
As of Tue Mar 31, 2026, the total assets managed under SBI Healthcare Opportunities Fund-growth stand at approximately ₹ 4,063.6 crore.
The SBI Healthcare Opportunities Fund-growth has delivered the following short-term performance:
- 3 Months Return: 5.80%
- 6 Months Return: 5.16%
The historical growth of the SBI Healthcare Opportunities Fund-growth is reflected through its CAGR returns:
- 3 Year CAGR: 24.35%
- 5 Year CAGR: 15.25%
- Return Since Launch: 16.36%
The portfolio of SBI Healthcare Opportunities Fund-growth is distributed across different asset classes as follows:
- Equity: 97.38%
- Debt Instruments: 0.07%
- Other Assets: 2.55%
The SBI Healthcare Opportunities Fund-growth is managed by Tanmaya Desai, representing SBI Mutual Fund.
The SBI Healthcare Opportunities Fund-growth investments are allocated across market caps in the following manner:
- Large Cap Stocks: 1.00%
- Mid Cap Stocks: 1.00%
- Small Cap Stocks: 1.00%
Top stock holdings of SBI Healthcare Opportunities Fund-growth include:
- Sun Pharmaceutical Industries Ltd – represents 1.00% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.97% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 12.11% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.64% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.18% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 11.18% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.65% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.86% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.94% of the portfolio
- Sun Pharmaceutical Industries Ltd – represents 10.02% of the portfolio
Major sector exposures in SBI Healthcare Opportunities Fund-growth are:
- Healthcare – accounts for 858.14% of the portfolio
- Materials – accounts for 27.95% of the portfolio
- Financial – accounts for 1.65% of the portfolio
